Study of the Effect of SZC on Serum Potassium and Serum Bicarbonate in Patients With Hyperkalemia and Metabolic Acidosis Associated With Chronic Kidney Disease
Clinical trial NCT04727528 · TERMINATED
Trial details
- NCT number
- NCT04727528
- Sponsor
- AstraZeneca
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-22
- Primary completion
- 2022-09-14
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.